MedTrace Logo

Novel Immune Markers in Patients With Multiple Sclerosis

NCT01026272 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2010-07-13

No results posted yet for this study

Summary

The investigators hypothesize that the endogenous cannabinoid signalling system has lost homeostasis in the disease multiple sclerosis (MS). To investigate a novel action of dietary fish oils, the investigators will administer a food frequency questionnaire to both healthy subjects and patients with MS. The investigators will first determine if there are differences between both populations of endogenous cannabinoids, and then determine whether dietary intake of fish oils alters these levels

Conditions

Sponsors & Collaborators

Principal Investigators

  • Michelle Sexton, ND · University of Washington

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-01-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01026272 on ClinicalTrials.gov